| 中文名 | SY-1365 |
|---|---|
| 英文名 | SY-1365 |
| 英文别名 |
Mevociclib
2-Pyridinecboxamide, N-[(1S,3R)-3-[[5-chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]-1-methylcyclohexyl]-5-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino] Inhibitor,triple negative breast cancer,TNBC,Mevociclib,Cyclin dendent kinase,SY1365,tumors,cancers,cell,inhibit,solid,CDK,small,SY 1365,CDK7/CycH/MAT1,lung Mevociclib,SY-1365 N-[(1S,3R)-3-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]-1-methylcyclohexyl]-5-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]-2-pyridinecboxamide N-[(1S,3R)-3-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-1-methylcyclohexyl]-5-[(2E)-4-(dimethylamino)but-2-enamido]pyridine-2-cboxamide SY-1365;SY 1365;SY N-((1S,3R)-3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)-1-methylcyclohexyl)-5-((E)-4-(dimethylamino)but-2-enamido)picolinamide |
| 描述 | SY-1365 是一种高选择性的 CDK7 共价抑制剂,具有治疗血液学疾病和实体肿瘤潜力。 |
|---|---|
| 相关类别 | |
| 靶点 |
CDK7 |
| 参考文献 |
| 分子式 | C31H35ClN8O2 |
|---|---|
| 分子量 | 587.12 |
| 储存条件 | -20°C,密闭,干燥 |